AstraZeneca Covid Vaccine

ByAlbert Laurin

Oct 15, 2020 ##aftermarket, ##astra, ##astrazeneca, ##betweenplays, ##covid, ##covid19, ##flu, ##investing, ##investor, ##market, ##marketbeat, ##marketwatch, ##medicine, ##premarket, ##profit, ##profitly, ##shares, ##simplywallstreet, ##stock, ##stockhouse, ##stocks, ##stocktwits, ##telehealth, ##trade, ##trending, ##trendingstocks, ##vaccine, ##wallstreet #aidanlock

AstraZeneca is on its way towards approving its first Covid vaccine in Australia but guess what, Europe and Canada and Indonesia as well as other countries are looking at its approval as well.

Theres also the deal the USA made for a treatment that AstraZeneca has on the table once approved, so why are we not hearing about this everyday.

This news is highly positive and could help the world feel hopeful when that’s what it needs.

More to come…

https://www.raps.org/news-and-articles/news-articles/2020/10/tga-moves-astrazenecas-vaccine-on-first-step-towar

https://www.fool.com/investing/2020/10/06/astrazenecas-coronavirus-vaccine-is-already-being/

https://www.upi.com/Top_News/US/2020/10/12/AstraZeneca-US-govt-sign-deal-for-COVID-19-antibody-treatment/1641602500260/

By Albert Laurin

Founder/CEO/President, Host, Content Creator and Commentary writer for Betweenplays StockMarket Strategies.

Lead author for Betweenplays since March 2020.

Albert Laurin is the founder of Betweenplays Media, an independent intelligence and media platform established in 2020. His work focuses on long-form analysis and direct, unscripted executive conversations across markets, technology, real estate, and geopolitics.

With a background in accounting, management, marketing, and law enforcement, Laurin applies a disciplined, real-world approach to evaluating financial structures, risk, and incentives. Betweenplays conducts non-paid interviews, preserving editorial independence.

In parallel with markets, Laurin is a real-estate broker in the Greater Montreal area, applying the same analytical rigor to real-world economic decisions.